Cargando…
A new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study
Management of cancer-associated venous thromboembolism (VTE) is essential in treatment selection and cancer prognosis. However, to date, there is no method to assess the risk of VTE specifically associated with advanced lung cancer. Our aim was to create a new risk assessment scoring system that can...
Autores principales: | Tsubata, Yukari, Hotta, Takamasa, Hamai, Kosuke, Furuya, Naoki, Yokoyama, Toshihide, Saito, Ryota, Nakamura, Atsushi, Masuda, Takeshi, Hamaguchi, Megumi, Kuyama, Shoichi, Honda, Ryoichi, Senoo, Tadashi, Nakanishi, Masamoto, Yamasaki, Masahiro, Ishikawa, Nobuhisa, Fujitaka, Kazunori, Kubota, Tetsuya, Kobayashi, Kunihiko, Isobe, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981807/ https://www.ncbi.nlm.nih.gov/pubmed/35379309 http://dx.doi.org/10.1186/s13045-022-01259-7 |
Ejemplares similares
-
Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study)
por: Tsubata, Yukari, et al.
Publicado: (2022) -
Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data
por: Tsubata, Yukari, et al.
Publicado: (2022) -
Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor‐mutant non‐small cell lung cancer: A prospective, multicenter, dose‐modification study
por: Tsubata, Yukari, et al.
Publicado: (2021) -
Acute Interstitial Lung Disease Induced by Rechallenge with Ceritinib
por: Hotta, Takamasa, et al.
Publicado: (2019) -
Nontuberculous Mycobacterium‐associated immune reconstitution inflammatory syndrome in a non‐HIV immunosuppressed patient
por: Kobayashi, Misato, et al.
Publicado: (2022)